Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants-Reference-Cited by-同舟云学术

Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants

Published:2022-05-31 Issue:5 Volume:5 Page:e2214321
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Pokorney Sean D.¹,Cocoros Noelle²,Al-Khalidi Hussein R.³,Haynes Kevin⁴,Li Shuang³,Al-Khatib Sana M.¹,Corrigan-Curay Jacqueline⁵,Driscoll Meighan Rogers²,Garcia Crystal²,Calvert Sara B.⁶,Harkins Thomas⁷,Jin Robert²,Knecht Daniel⁸,Levenson Mark⁹,Lin Nancy D.¹⁰,Martin David¹¹,McCall Debbe¹²,McMahill-Walraven Cheryl⁸,Nair Vinit⁷,Parlett Lauren⁴,Petrone Andrew²,Temple Robert⁵,Zhang Rongmei⁹,Zhou Yunping⁷,Platt Richard²,Granger Christopher B.¹

Affiliation:

1. Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina

2. Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts

3. Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina

4. HealthCore Inc, Alexandria, Virginia

5. Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

6. Clinical Trials Transformation Initiative, Durham, North Carolina

7. Humana Healthcare Research Inc, Louisville, Kentucky

8. Aetna Inc, Blue Bell, Pennsylvania

9. Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration

10. OptumInsight Life Sciences Inc, Boston, Massachusetts

11. Moderna Inc, Cambridge, Massachusetts

12. Rowan Tree Perspectives Consulting, Murrieta, California

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2792820/pokorney_2022_oi_220422_1653320685.48442.pdf

Reference37 articles.

1. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.;Wann;J Am Coll Cardiol,2011

2. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.;Miyasaka;Circulation,2006

3. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study.;Wolf;Arch Intern Med,1987

4. Risk of stroke in non-rheumatic atrial fibrillation.;Flegel;Lancet,1987

5. Current status of stroke risk stratification in patients with atrial fibrillation.;Hart;Stroke,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients;Heart Rhythm O2;2024-05

3. Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2);Thrombosis Research;2023-07

4. Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren’t so simple;Clinical Trials;2023-06-15

5. High rates of oral anticoagulation in atrial fibrillation patients observed in a large multi-specialty health system in the Northeast;Journal of Interventional Cardiac Electrophysiology;2022-10-20